Substantial increases in cervical cancer inequalities worldwide without enhanced human papillomavirus vaccination and screening efforts: a global modelling study
Listen to this summary
This study aimed to assess the trajectory of cervical cancer elimination in low- and middle-income countries (LMICs) compared to high-income countries (HICs) and to evaluate the impact of enhanced HPV vaccination and screening strategies on existing inequalities. The findings indicate that without significant improvements in vaccination and screening efforts, cervical cancer incidence will decrease minimally in LMICs, leading to a dramatic increase in inequalities by 2105. Achieving WHO elimination targets and implementing universal vaccination strategies are essential for reducing these disparities and achieving cervical cancer elimination in LMICs.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Lancet (London, England)
View all →May 10, 2026 · Lancet (London, England)
Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial
May 10, 2026 · Lancet (London, England)
Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication
May 10, 2026 · Lancet (London, England)
Impact of introducing RTS,S/AS01<sub>E</sub> malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme
May 9, 2026 · Lancet (London, England)
The role of community-based blood pressure screening in improving hypertension care
May 8, 2026 · Lancet (London, England)
Long-term effects of colonoscopy screening on colorectal cancer incidence and mortality: a multicountry, population-based randomised controlled trial
May 3, 2026 · Lancet (London, England)
Effects of ovarian ablation or suppression on breast cancer recurrence and survival: patient-level meta-analysis of 15 000 women in 23 randomised trials
More in Nuclear Medicine
View all →May 6, 2026 · The New England journal of medicine
Daraxonrasib in Previously Treated Advanced <em>RAS</em>-Mutated Pancreatic Cancer
May 6, 2026 · The New England journal of medicine
Cerebral Amyloid Angiopathy
May 6, 2026 · The New England journal of medicine
Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults
May 6, 2026 · The New England journal of medicine
Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies
Apr 29, 2026 · The New England journal of medicine
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors
Apr 29, 2026 · The New England journal of medicine
Pulmonary Tuberculosis Detection with MiniDock MTB Using Swab Samples
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


